Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1,2,3-triazole-4-yl derivatives as topoisomerase II inhibitors

References

• Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, et al. Trends and patterns of disparities in cancer mortality among us counties, 1980–2014. JAMA 2017;317:388–406.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Fortin S, Bérubé G. Advances in the development of hybrid anticancer drugs. Expert Opin Drug Discov 2013;8:1029–47.
   PubMed Web of Science ®Google Scholar
• Belmont P, Dorange I. Acridine/acridone: a simple scaffold with a wide range of application in oncology. Expert Opin Ther Pat 2008;18:1211–24.
   Web of Science ®Google Scholar
• Sayed M, Krishnamurthy B, Pal H. Unraveling multiple binding modes of acridine orange to DNA using a multispectroscopic approach. Phys Chem Chem Phys 2016;18:24642–53.
   PubMed Web of Science ®Google Scholar
• Pogorelcnik B, Perdih A, Solmajer T. Recent developments of DNA poisons—human DNA topoisomerase IIα inhibitors—as anticancer agents. Curr Pharm Des 2013;19:2474–88.
   PubMed Web of Science ®Google Scholar
• Cholewiński G, Dzierzbicka K, Kołodziejczyk AM. Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacol Rep 2011;63:305–36.
   PubMed Web of Science ®Google Scholar
• Bridewell DJ, Finlay GJ, Baguley BC. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II. Cancer Chemother Pharmacol 1999;43:302–8.
   PubMed Web of Science ®Google Scholar
• Demeunynck M. Antitumour acridines. Expert Opin Ther Pat 2004;14:55–70.
   Web of Science ®Google Scholar
• Gensicka-Kowalewska M, Cholewiński G, Dzierzbicka K. Recent developments in the synthesis and biological activity of acridine/acridone analogues. RSC Adv 2017;7:15776–804.
   Web of Science ®Google Scholar
• Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. BioMed Res Int 2013;2013:963248.
   PubMed Web of Science ®Google Scholar
• Wu X-Q, Huang C, Jia Y-M, et al. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Eur J Med Chem 2014;74:717–25.
   PubMed Web of Science ®Google Scholar
• Fong W-F, Shen X-L, Globisch C, et al. Methoxylation of 3′,4′-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells. Bioorg Med Chem 2008;16:3694–703.
   PubMed Web of Science ®Google Scholar
• Agalave SG, Maujan SR, Pore VS. Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J 2011;6:2696–718.
   PubMed Web of Science ®Google Scholar
• Thirumurugan P, Matosiuk D, Jozwiak K. Click chemistry for drug development and diverse chemical-biology applications. Chem Rev 2013;113:4905–79.
   PubMed Web of Science ®Google Scholar
• Mackay HJ, Hill M, Twelves C, et al. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer. Ann Oncol 2003;14:1264–9.
   PubMed Web of Science ®Google Scholar
• van Staveren MC, Opdam F, Guchelaar HJ, et al. Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients. Cancer Chemother Pharmacol 2015;76:47–52.
   PubMed Web of Science ®Google Scholar
• Keppel Hesselink JM, Kopsky DJ. Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. J Neurol 2017;264:1617–21.
   PubMed Web of Science ®Google Scholar
• Yang M, Kozminski DJ, Wold LA, et al. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Res Treat 2012;134:603–15.
   PubMed Web of Science ®Google Scholar
• Razmaraii N, Babaei H, Mohajjel Nayebi A, et al. Cardioprotective effect of phenytoin on doxorubicin-induced cardiac toxicity in a rat model. J Cardiovasc Pharmacol 2016;67:237–45.
   PubMed Web of Science ®Google Scholar
• Michaelis M, Doerr WH, Cinatl J Jr. Valproic acid as anti-cancer drug. Curr Pharm Des 2007;13:3378–93.
   PubMed Web of Science ®Google Scholar
• Göttlicher M, Minucci S, Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001;20:6969–78.
   PubMed Web of Science ®Google Scholar
• Han M, Küçükgüzel ŞG. Anticancer and antimicrobial activities of naproxen and naproxen derivatives. Mini Rev Med Chem 2020;20:1300–10.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JE, Lim DY, et al. Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev Res 2014;7:236–45.
   PubMed Web of Science ®Google Scholar
• Dheer D, Singh V, Shankar R. Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 2017;71:30–54.
   PubMed Web of Science ®Google Scholar
• Nagarjuna G, Yurt S, Jadhav KG, Venkataraman D. Impact of pendant 1, 2, 3-triazole on the synthesis and properties of thiophene-based polymers. Macromolecules 2010;43:8045–50.
   Web of Science ®Google Scholar
• Bock VD, Hiemstra H, Van Maarseveen JH. Cui‐catalyzed alkyne–azide “click” cycloadditions from a mechanistic and synthetic perspective. Eur J Org Chem 2006;2006:51–68.
   Web of Science ®Google Scholar
• Bräse S, Gil C, Knepper K, Zimmermann V. Organic azides: an exploding diversity of a unique class of compounds. Angew Chem Int Ed Engl 2005;44:5188–240.
   PubMed Web of Science ®Google Scholar
• Taherpour AA, Kvaskoff D, Bernhardt PV, Wentrup C. 9‐Azidoacridine and 9‐acridinylnitrene. J Phys Org Chem 2010;23:382–9.
   Web of Science ®Google Scholar
• Meldal M, Tornøe CW. Cu-catalyzed azide-alkyne cycloaddition. Chem Rev 2008;108:2952–3015.
   PubMed Web of Science ®Google Scholar
• Kudale AA, Kendall J, Warford CC, et al. Hydrolysis-free synthesis of 3-aminocoumarins. Tetrahedron Lett 2007;48:5077–80.
   Web of Science ®Google Scholar
• Al-Nuzal SMD. New derivatives of 3-substituted 5, 5-diphenyl-2, 4-imidazolidinedione as anticonvulsant and antiepileptic candidates. J Appl Chem 2014;3:1319–26.
   Google Scholar
• Krim J, Taourirte M, Engels JW. Synthesis of 1,4-disubstituted mono and bis-triazolocarbo-acyclonucleoside analogues of 9-(4-hydroxybutyl)guanine by Cu(I)-catalyzed click azide-alkyne cycloaddition. Molecules 2011;17:179–90.
   PubMed Web of Science ®Google Scholar
• Krivonogov V, Tolstikov G, Murinov YI, et al. Alkylation of 6-methyluracil and its derivatives. Russ J Appl Chem 1997;70:301–6.
   Web of Science ®Google Scholar
• Tesak JL. Study of click chemistry: working towards ‘clicking’ a non-steroidal anti-inflammatory to an apoptosis inhibitor Q-VD-OPH [dissertation]. Miami University; 2012.
   Google Scholar
• Ragab FAF, Abou-Seri SM, Abdel-Aziz SA, et al. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety. Eur J Med Chem 2017;138:140–51.
   PubMed Web of Science ®Google Scholar
• Hofny HA, Mohamed MFA, Gomaa HAM, et al. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Bioorg Chem 2021;112:104920.
   PubMed Web of Science ®Google Scholar
• Pasqualetto G, Schepelmann M, Varricchio C, et al. Computational studies towards the identification of novel rhodopsin-binding compounds as chemical chaperones for misfolded opsins. Molecules 2020;25:4904.
   PubMed Web of Science ®Google Scholar
• Kishk SM, Kishk RM, Yassen ASA, et al. Molecular insights into human transmembrane protease serine-2 (TMPS2) inhibitors against SARS-COV2: homology modelling, molecular dynamics, and docking studies. Molecules 2020;25:5007.
   PubMed Web of Science ®Google Scholar
• Wu C-C, Li Y-C, Wang Y-R, et al. On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs. Nucleic Acids Res 2013;41:10630–40.
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). Chemical Computing Group Ulc; 2020. Available from: https://www.chemcomp.com/products.htm.
   Google Scholar
• Protein Preparation Wizard; 2021. Available from: https://www.Schrodinger.Com/products/protein-preparation-wizard.
   Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 2013;27:221–34.
   PubMed Web of Science ®Google Scholar
• Schrödinger release 2020-1. New York (NY)/New York (NY). Desmond Molecular Dynamics System, D. E. Shaw Research/Maestro-Desmond Interoperability Tools, Schrödinger; 2020. Available from: https://www.schrodinger.com/products/desmond.
   Google Scholar
• Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Informat Model 2011;51:69–82.
   PubMed Web of Science ®Google Scholar
• Himo F, Lovell T, Hilgraf R, et al. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J Am Chem Soc 2005;127:210–6.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Chapter 4: Apoptosis and beyond: cytometry in studies of programmed cell death. In: Darzynkiewicz Z, Holden E, Orfao A, Telford W, Wlodkowic D, ed. Methods in cell biology. London: Elsevier; 2011.
   Google Scholar